The Importance of Cellular Immunity in the Development of Vaccines and Therapeutics for COVID-19.

Schlom, Jeffrey; Donahue, Renee N

Schlom, Jeffrey; Donahue, Renee N.

Affiliation

Schlom J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Donahue RN; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

J Infect Dis ; 222(9): 1435-1438, 2020 10 01.

Article in En | MEDLINE | ID: mdl-32651586

ABSTRACT

ABSTRACT

It is important to develop vaccines that can also mediate T-cell responses to SARS-CoV-2 to limit severity of infections, and to analyze the cellular immunome in the use of anti-SARS-CoV-2 therapeutics.

Subject(s)

Aging/immunology; Betacoronavirus/immunology; Coronavirus Infections/immunology; Immunity, Cellular; Leukocytes, Mononuclear/immunology; Pneumonia, Viral/immunology; Viral Vaccines; Antigens, CD/blood; COVID-19; COVID-19 Vaccines; Coronavirus Infections/drug therapy; Coronavirus Infections/prevention & control; Drug Development; Flow Cytometry; Humans; Pandemics/prevention & control; Pneumonia, Viral/drug therapy; Pneumonia, Viral/prevention & control; SARS-CoV-2

Key words

COVID-19; SARS-CoV-2; T-cell immunity; human immunome; immunology; vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Aging / Leukocytes, Mononuclear / Viral Vaccines / Coronavirus Infections / Betacoronavirus / Immunity, Cellular Limits: Humans Language: En Journal: J Infect Dis Year: 2020 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google